Story thread · 2 reports / 2 sources
AbbVie-allied ADARx aims for IPO with 3 drugs in the clinic
endpts.com · 10d
RNA interference company ADARx Pharmaceuticals revealed its intentions to go public in a Friday night SEC filing, trying to take advantage of the industry's IPO momentum. The San Diego biotech plans to list on the ...
First report: Adarx Pharmaceuticals Files For US IPO to Fund RNA Treatment — bloomberg.com, 10d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.